CHEST® Resource Center
Won - Figure 44
Another Unknown
FIG. 44: The question that remains for TE-CSA is similar to the question for Op-CSA: What, if any, are the long-term consequences with central apneas under these conditions? It may seem intuitive that eliminating the hypoxemia and arousals due to CSA would be beneficial from both the symptomatic, as well as medical viewpoint, but as we learned from the SERVE-HF trial,[12] this is not always the case, and we do not really know whether we are doing any good. More importantly, we do not know whether we are doing harm by treating these patients with PAP therapy.
Won C. Chest 2016;00.
References
[12]
Cowie MR, Woehrle H, Wegscheider K, et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. N Engl J Med. 2015;373:1095–1105.
